Documents
Médias
XIFAXAN® 550mg (rifaximin-α) Registered for Reduction of Recurrence of Episodes of Overt Hepatic Encephalopathy in the EU*
Editeur
Alfa-Wassermann-Norgine
Publications
(
1
)